Mr. Beshar was Executive Vice President and Chief Financial Officer of NPS Pharmaceuticals until February 2015 when the company was sold to Shire plc. He joined NPS Pharmaceuticals in 2007 and at various points during his tenure was responsible for financial management, investor relations, information technology, technical operations, supply-chain management, corporate development, alliance management, project management, contracts & outsourcing, and facilities. Prior to joining NPS, Mr. Beshar served as Executive Vice President and Chief Financial Officer of Cambrex Corporation, a global life sciences company. Mr. Beshar began his career with Arthur Andersen & Co. and is a certified public accountant. He obtained his bachelor’s degree in Accounting and Finance from Michigan State University and is a graduate of The Executive Program at the Darden Graduate School of Business at the University of Virginia. Mr Beshar also serves on the Board of Directors, Audit Committee (chairman) and Compensation committee of Regenxbio Inc.